C

Christian Medical College | Pulmonary Medicine

Research site

(Unclaimed)

Location

Christian Medical College,Ida Scudder Road,, Vellore, Tamil Nadu, India

Site insights

Top conditions

Top treatments

Milvexian

Basimglurant

Denosumab

Doxorubicin

Atrasentan

Finerenone

INNO-206

Parent organization

This site is a part of Christian Medical College

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 7 total trials

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

Enrolling

Ischemic Stroke; Ischemic Attack, Transient

Drug: Placebo

Drug: Milvexian

A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus

Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys' ability to work pr...

Active, not recruiting

Chronic Kidney Disease

Type 2 Diabetes Mellitus

Drug: Finerenone (Kerendia, BAY94-8862)

Atrasentan in Patients With IgA Nephropathy (ALIGN)

The ALIGN Study is a phase 3, double-blind, placebo-controlled study to compare the efficacy and safety of atrasentan to placebo in patients with IgA...

Active, not recruiting

Immunoglobulin A Nephropathy

IgA Nephropathy

Drug: Placebo

Drug: Atrasentan

Basimglurant in Children, Adolescents, and Young Adults With TSC

The study intends to show that basimglurant provides effective seizure control in children, adolescents and young adults with Tuberous Sclerosis Comp...

Enrolling

Tuberous Sclerosis Complex

Drug: Placebo with crossover to Basimglurant

Drug: Basimglurant with crossover to Placebo